Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. University College London Hospitals NHS Foundation Trust

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

University College London Hospitals NHS Foundation Trust (UCLH), headquartered at 250 Euston Road, London NW1 2PG, is one of the largest and most prestigious National Health Service (NHS) foundation trusts in the United Kingdom. Closely partnered with University College London (UCL), the trust seamlessly translates world-class clinical research into advanced patient care, consistently ranking as a top acute teaching trust in England. UCLH operates multiple specialized facilities across central London, including its flagship University College Hospital, the National Hospital for Neurology and Neurosurgery, and the Royal National ENT and Eastman Dental Hospitals. It is highly regarded for its comprehensive acute services and expertise in major specialties such as oncology, cardiac diseases, women's health, neurosciences, and oral health.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Hospital

Business Subcategory

Source: Google. Hospital
Source: Trial-derived.
227Total Trials
Source: Trial-derived.
57Recruiting Trials
Source: Trial-derived.
103Active Trials
Source: Trial-derived.
89Completed Trials
Source: Trial-derived.
390Unique Conditions
Source: Trial-derived.
219Unique Sponsors

Conditions

Source: Trial-derived. Multiple Myeloma (8)Source: Trial-derived. Lung Cancer (7)Source: Trial-derived. Neoplasms (6)Source: Trial-derived. Ovarian Cancer (6)Source: Trial-derived. Prostate Cancer (5)Source: Trial-derived. Surgery (5)Source: Trial-derived. Cancer (4)Source: Trial-derived. Bladder Cancer (3)

Sponsors

Source: Trial-derived. University College, London (42)Source: Trial-derived. Hoffmann-La Roche (17)Source: Trial-derived. Janssen Research & Development, LLC (11)Source: Trial-derived. University College London Hospitals (11)Source: Trial-derived. Cancer Research UK (10)Source: Trial-derived. Merck Sharp & Dohme LLC (10)Source: Trial-derived. National Institute for Health Research, United Kingdom (9)Source: Trial-derived. Pfizer (9)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. CT Scan
Source: AI-inferred. PET-CT
Source: AI-inferred. MRI
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. Ultrasound
Source: AI-inferred. Ambulatory ECG / Holter monitoring

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Sequencing / genomics

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Lumbar puncture

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic patient diary (eDiary)
Source: AI-inferred. Ophthalmological examination
Source: AI-inferred. PD-L1 immunohistochemistry (CPS) testing
Source: AI-inferred. 10-meter walk test
Source: AI-inferred. Arterial blood gas analysis
Source: AI-inferred. Autologous cell therapy product administration
Source: AI-inferred. Autologous haematopoietic stem cell transplantation
Source: AI-inferred. Blood compatibility testing